MARKET

NNVC

NNVC

NANOVIRICIDES
AMEX

Real-time Quotes | Nasdaq Last Sale

3.990
-0.120
-2.92%
After Hours: 3.960 -0.03 -0.75% 17:03 04/19 EDT
OPEN
4.020
PREV CLOSE
4.110
HIGH
4.110
LOW
3.880
VOLUME
171.59K
TURNOVER
--
52 WEEK HIGH
12.20
52 WEEK LOW
2.850
MARKET CAP
42.60M
P/E (TTM)
-2.0937
1D
5D
1M
3M
1Y
5Y
Ebola vaccine: Why it's taking so long to make one
Efforts to develop an Ebola vaccine have been in the works for some time. But experts say it's unlikely to see one available anytime soon.
CNBC.com · 3d ago
Viral Conjunctivitis Pipeline Drugs Market Report 2021 Growth Factors, Research Methodology With Impact of COVID-19 and Global Forecast 2026
Apr 12, 2021 (The Expresswire) -- "Final Report will add the analysis of the impact of COVID-19 on this industry" Global “Viral Conjunctivitis Pipeline Drugs...
The Express Wire · 04/12 08:55
Viral Conjunctivitis Pipeline Drugs Market Share, Growth, Size 2021: Global Sales Revenue, Emerging Technologies, Key Players Analysis, Development Status, Opportunity Assessment and Industry Expansion Strategies 2027
The Express Wire · 04/07 05:53
Global Corona Virus Treatment Market Analysis 2021 By Share, Size, Industry Demand, Worldwide Research, Prominent Players, Emerging Trends, Investment Opportunities and Revenue Expectation till 2026
Apr 05, 2021 (The Expresswire) -- Global Corona Virus Treatment Market Research Report 2021: The Global Corona Virus Treatment Market report provides revenue...
The Express Wire · 04/05 10:47
Influenza A Virus, H3N2 Subtype Infections Drug Market Revenue, Trends, Growth, Share, Size and Forecast 2020-2027 by Ameco Research
pune, India, Tue, 30 Mar 2021 02:46:55 / Comserve Inc. / -- Ameco Research indicates that the Global Influenza A Virus, H3N2 Subtype Infections Drug Market...
Comserve · 03/31 13:09
Global H3N2 Infection Treatment Market Insights, Overview, Analysis and Forecast 2015-2026
Mar 30, 2021 (Heraldkeepers) -- This report researches the worldwide H3N2 Infection Treatment market size (value) in key regions like United States, Europe,...
Heraldkeepers · 03/30 16:22
NIO, TAL Education among premarket losers' pack
HighPoint Resources (HPR) -17%.Vuzix (VUZI) -16% on pricing $85M stock offering.Cellect Biotechnology (APOP) -12%GAN (GAN) -10% on Q4 earnings release.Hall of Fame Resort & Entertainment (HOFV) -9%.Cinedigm (CIDM) -8%.Co-Diagnostics (CODX) -8% on FY earnin...
Seekingalpha · 03/26 12:20
Nanostructured Drug Market Overview, New Opportunities & SWOT Analysis by 2026 | Pfizer, Moderna, NanoViricides, Celgene
Mar 12, 2021 (Market Insight Reports) -- Nanostructured Drug Market Comprehensive Study is an expert and top to bottom investigation on the momentum...
Market Insight Reports · 03/12 13:32
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NNVC. Analyze the recent business situations of NANOVIRICIDES through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 1 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NNVC stock price target is 14.50 with a high estimate of 14.50 and a low estimate of 14.50.
EPS
Institutional Holdings
Institutions: 38
Institutional Holdings: 3.05M
% Owned: 28.53%
Shares Outstanding: 10.68M
TypeInstitutionsShares
Increased
3
85.77K
New
2
25.06K
Decreased
6
173.75K
Sold Out
4
1.42M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Biotechnology & Medical Research
-1.60%
Pharmaceuticals & Medical Research
-0.26%
Key Executives
Chairman/President/Executive Director
Anil Diwan
Chief Financial Officer
Meeta Vyas
Independent Director
Stanley Glick
Independent Director
Makarand Jawadekar
Independent Director
Theodore Rokita
Independent Director
Brian Zucker
No Data
About NNVC
NanoViricides, Inc. is a nano-biopharmaceutical research and development company. The Company is engaged the discovery, development, and commercialization of drugs to combat viral infections using its nanomedicines technology. The Company provides nanoviricide technology, which enables direct attacks at multiple points on a virus particle. The nanoviricide technology is engaged in both attacking extracellular virus thereby breaking the reinfection cycle, and simultaneously disrupting intracellular production of the virus, thereby enabling complete control of a virus infection. The nanoviricide technology also simultaneously enables attacking the intracellular reproduction of the virus by incorporating one or more active pharmaceutical ingredients (APIs) within the core of the nanoviricide. The Company’s lead product candidate is NV-HHV-101 in the HerpeCide program, as a skin cream for the treatment of shingles rash.

Webull offers kinds of NanoViricides Inc stock information, including AMEX:NNVC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NNVC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NNVC stock methods without spending real money on the virtual paper trading platform.